糖尿病中女性性功能障碍的模式和预测因素
Ankur Sachdeva1, Vipin Kumar2, Shilpa Khullar3
1Department of Psychiatry, ESIC Medical College and Hospital, NH-3, NIT, Faridabad, Haryana, India.
The National medical journal of India
|May 1, 2024
概括
性功能障碍影响44%的糖尿病女性,影响欲望,兴奋和高潮. 诸如年龄,BMI和胰岛素治疗等因素可以预测这种常见的并发症.
科学领域:
- 内分泌学 在内分泌学.
- 性健康 性的健康
- 妇女健康 妇女健康
背景情况:
- 患有糖尿病 (DM) 的女性的性功能障碍往往因为耻辱而被忽视.
- 印度对DM对女性性功能影响的研究有限.
- 这项研究探讨了患有DM的女性性功能障碍的模式和预测因素.
研究的目的:
- 调查1型和2型糖尿病女性性功能障碍的患病率和模式.
- 确定这一群体中性功能障碍的社会人口统计和临床预测因素.
- 将DM女性的性功能与对照组进行比较.
主要方法:
- 一项基于问卷的横截面研究与50名患有DM的女性和50名对照进行了.
- 参与者从医疗门诊部门招募.
- 使用女性性功能指数 (FSFI),医院焦虑和抑郁量表 (HADS) 来进行评估.
主要成果:
- 44%的患有DM的女性经历了性功能障碍,而对照组的这一比例为20% (p<0.01).
- 在欲望,兴奋,滑和高潮领域观察到功能障碍.
- 更高的年龄,BMI,DM持续时间,胰岛素使用和DM并发症预测性功能障碍增加.
结论:
- 性功能障碍是患有糖尿病的女性的一个普遍问题,无论DM类型如何.
- 抑郁和焦虑等心理因素可能并存,但并不是唯一的预测因素.
- 临床参数显著影响DM妇女的性健康结果.
相关概念视频
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Pathophysiology of Diabetes
922
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
922
Diabetes: Symptoms, Diagnosis, and Complications
526
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
526
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192


